先天性筋ジストロフィー CMD
WordNet
- any degenerative disorder resulting from inadequate or faulty nutrition
- of or relating to or consisting of muscle; "muscular contraction"
- having or suggesting great physical power or force; "the muscular and passionate Fifth Symphony"
- present at birth but not necessarily hereditary; acquired during fetal development (同)inborn, innate
PrepTutorEJDIC
- 栄養障害 / 筋萎縮症,筋ジストロフィー(筋肉の退化・萎縮・運動障害などが起こる病気)
- 『助肉の』,筋肉でできた / 筋肉による / 筋肉の発達した
- (病気・身体的欠陥など)生まれつきの,先天的な
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/10/15 18:42:36」(JST)
[Wiki en表示]
|
This article has multiple issues. Please help improve it or discuss these issues on the talk page.
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2007) |
|
This article may need to be rewritten entirely to comply with Wikipedia's quality standards, as article. You can help. The discussion page may contain suggestions. (February 2009) |
|
This article needs attention from an expert in February 2009. Please add a reason or a talk parameter to this template to explain the issue with the . WikiProject February 2009 may be able to help recruit an expert. (February 2009) |
|
Congenital muscular dystrophy |
Classification and external resources |
ICD-10 |
G71.2 |
ICD-9 |
359.0 |
eMedicine |
neuro/549 |
Congenital muscular dystrophy (CMD) is muscular dystrophy that is present at birth. CMD includes a number of autosomal recessive[1] diseases of muscle weakness and possible joint deformities, present at birth and slowly progressing. Life expectancies for affected individuals vary, although some forms of CMD do not affect life span at all.
Contents
- 1 Management
- 2 Classification
- 3 Related organizations
- 4 See also
- 5 References
- 6 External links
|
Management
Treatment is supportive.[2]
Physical and occupational therapy, surgery, wheelchairs and other assistive technology may be helpful.
Currently there is no cure.
Classification
All such known dystrophies are genetically recessive and result from mutations in a variety of different genes, including those encoding the laminin-α2 chain, fukutin-related protein, LARGE and fukutin, amongst others.
A classification for CMDs had been proposed in 2004 by Muntoni and Voit, based on genetic mutation.[3]
- Genes encoding for structural proteins of the basal membrane or extracellular matrix of the skeletal muscle fibres.
- Genes encoding for putative or demonstrated glycosyltransferases, that in turn affect the glycosylation of dystroglycan, an external membrane protein of the basal membrane.
- Other
Name |
Abbreviation |
Group |
OMIM |
Gene and locus |
Laminin-α2–deficient CMD |
MDC1A |
basal membrane/extracellular matrix |
607855 |
LAMA2 at 6q22-q23 |
Ullrich congenital muscular dystrophy |
UCMDs 1, 2 and 3 |
basal membrane/extracellular matrix |
254090 |
COL6A1 at 2q37, COL6A2 at 21q22.3, COL6A3 at 21q22.3 |
Walker-Warburg syndrome |
WWS |
glycosylation of dystroglycan |
236670 |
POMT1 at 9q34.1 and POMT2 at 14q24.3 |
Muscle-eye-brain disease |
MEB |
glycosylation of dystroglycan |
253280 |
POMGNT1 at 1p34-p33 |
Fukuyama CMD |
FCMD |
glycosylation of dystroglycan |
253800 |
FKTN at 9q31 |
CMD plus secondary laminin deficiency 1 |
MDC1B |
glycosylation of dystroglycan |
604801 |
? at 1q42 |
CMD plus secondary laminin deficiency 2 |
MDC1C |
glycosylation of dystroglycan |
606612 |
FKRP at 19q13.3 |
CMD with mental retardation and pachygyria |
MDC1D |
glycosylation of dystroglycan |
608840 |
LARGE at 22q12.3-q13.1 |
Rigid spine with muscular dystrophy Type 1 |
RSMD1 |
other |
602771 |
SEPN1 at 1p36-p35 |
|
|
|
613204 |
ITGA7 at 12q13 |
Related organizations
Cure CMD, a Congenital Muscular Dystrophy specific non-profit organization, incorporated in May 2008, and received tax exempt 501 (c)(3) status from the IRS in August 2008. Cure CMD’s mission is to bring research, treatments and in the future, a cure for Congenital Muscular Dystrophies. By focusing on this mission, Cure CMD will find and fund high potential research and clinical trials. You can find more information at www.curecmd.org.
See also
- Muscular Dystrophy Association (USA)
- Muscular Dystrophy Campaign (UK)
References
- ^ Reed UC (March 2009). "Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects". Arq Neuropsiquiatr 67 (1): 144–68. PMID 19330236. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000100038&lng=en&nrm=iso&tlng=en.
- ^ Collins J, Bönnemann CG (March 2010). "Congenital muscular dystrophies: toward molecular therapeutic interventions". Curr Neurol Neurosci Rep 10 (2): 83–91. doi:10.1007/s11910-010-0092-8. PMID 20425232.
- ^ Muntoni F, Voit T (2004). "The congenital muscular dystrophies in 2004: a century of exciting progress". Neuromuscul. Disord. 14 (10): 635–49. doi:10.1016/j.nmd.2004.06.009. PMID 15351421. http://www.enmc.org/uploaded//publicatie/CMD2004.pdf.
External links
- Cure CMD
- GeneReview/NIH/UW entry on Congenital Muscular Dystrophy Overview
- Muscular Dystrophy Association (Greece)
Muscular dystrophy
|
|
The Nine Primary Muscular Dystrophies |
Congenital • dystrophin (Becker's, Duchenne) • Distal • Emery-Dreifuss • Facioscapulohumeral • Limb-girdle muscular dystrophy • Myotonic • Oculopharyngeal
|
|
Related topics
|
|
National/International Organizations |
Muscular Dystrophy Association (USA) • Muscular Dystrophy Canada • Myotonic Dystrophy Foundation
|
|
US government Institutes and Legislation |
NINDS • NIAMS • NICHD • MD CARE Act • Genetic Information Nondiscrimination Act • Americans with Disabilities Act of 1990
|
|
National/International Events |
MDA Show of Strength (USA) • Décrypthon (France)
|
|
Recent or Ongoing Clinical Trials |
Stamulumab (MYO-029)
|
|
|
anat (h/n, u, t/d, a/p, l)/phys/devp/hist
|
noco(m, s, c)/cong(d)/tumr, sysi/epon, injr
|
|
|
|
|
Diseases of myoneural junction and muscle / neuromuscular disease (G70–G73, 358–359)
|
|
Neuromuscular-
junction disease |
- autoimmune
- Myasthenia gravis
- Lambert–Eaton myasthenic syndrome
|
|
Myopathy/
congenital myopathy |
Muscular dystrophy
(DAPC) |
AD |
- Limb-girdle muscular dystrophy 1
- Oculopharyngeal
- Facioscapulohumeral
- Myotonic
- Distal (most)
|
|
AR |
- Limb-girdle muscular dystrophy 2
- Congenital
- Fukuyama
- Ullrich
- Walker–Warburg
|
|
XR |
- dystrophin
- Emery–Dreifuss
|
|
|
Other structural |
- collagen disease
- PTP disease
- adaptor protein disease
- BIN1-linked centronuclear myopathy
- cytoskeleton disease
- Nemaline myopathy
- Zaspopathy
|
|
Channelopathy |
Myotonia |
- Myotonia congenita
- Thomsen disease
- Neuromyotonia/Isaacs syndrome
- Paramyotonia congenita
|
|
Periodic paralysis |
|
|
Other |
|
|
|
Mitochondrial myopathy |
|
|
Other |
|
|
|
|
anat (h/n, u, t/d, a/p, l)/phys/devp/hist
|
noco(m, s, c)/cong(d)/tumr, sysi/epon, injr
|
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.
- Jensen BS1, Willer T2, Saade DN1, Cox MO3, Mozaffar T4, Scavina M5, Stefans VA6, Winder TL7,8, Campbell KP2, Moore SA3, Mathews KD1.
- Human mutation.Hum Mutat.2015 Dec;36(12):1159-63. doi: 10.1002/humu.22898. Epub 2015 Sep 23.
- Mutations in GDP-mannose pyrophosphorylase B (GMPPB), a catalyst for the formation of the sugar donor GDP-mannose, were recently identified as a cause of muscular dystrophy resulting from abnormal glycosylation of α-dystroglycan. In this series, we report nine unrelated individuals with GMPPB-assoc
- PMID 26310427
- Merosin-deficient congenital muscular dystrophy: A novel homozygous mutation in the laminin-2 gene.
- Turner C1, Mein R2, Sharpe C3, Love DR4.
- Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.J Clin Neurosci.2015 Dec;22(12):1983-5. doi: 10.1016/j.jocn.2015.04.016. Epub 2015 Aug 4.
- Merosin deficient congenital muscular dystrophy (MDC1A) is an autosomal recessive disorder characterized by mutations in the LAMA2 gene at chromosome 6q22-23. This gene spans 65 exons and encodes the α2 chain subunit of laminin-2. A variety of deletions, missense, nonsense and splice site mutations
- PMID 26249246
- Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.
- Whittaker RG1, Herrmann DN2, Bansagi B2, Hasan BA2, Lofra RM2, Logigian EL2, Sowden JE2, Almodovar JL2, Littleton JT2, Zuchner S2, Horvath R2, Lochmüller H2.
- Neurology.Neurology.2015 Dec 1;85(22):1964-71. doi: 10.1212/WNL.0000000000002185. Epub 2015 Oct 30.
- OBJECTIVES: To describe the clinical and electrophysiologic features of synaptotagmin II (SYT2) mutations, a novel neuromuscular syndrome characterized by foot deformities and fatigable ocular and lower limb weakness, and the response to modulators of acetylcholine release.METHODS: We performed deta
- PMID 26519543
Japanese Journal
- 縦隔奇形種を合併した福山型先天性筋ジストロフィーの1例
- 梶野 幸子,石垣 景子,島田 姿野,伊藤 進,唐木 克二,川島 章子,土屋 晶義,村上 てるみ,佐藤 孝俊,齊藤 崇,西川 俊郎,世川 修,大澤 眞木子,西川 愛子,KAJINO Sachiko,ISHIGAKI Keiko,SHIMADA Shino,NISHIKAWA Aiko,ITO Susumu,KARAKI Katsuji,KAWASHIMA Shoko,TSUCHIYA Masayoshi,MURAKAMI Terumi,SATO Takatoshi,SAITO Takashi,NISHIKAWA Toshio,SEGAWA Osamu,OSAWA Makiko
- 東京女子医科大学雑誌 83(臨時増刊(大澤眞木子教授退任記念特別)), E358-E361, 2013-01-31
- NAID 120005296664
- 小峯 聡,小平 かやの,池谷 紀代子,斎藤 加代子,大澤 眞木子,KOMINE Satoshi,KODAIRA Kayano,IKEYA Kiyoko,SAITO Kayoko,OSAWA Makiko
- 東京女子医科大学雑誌 83(臨時増刊(大澤眞木子教授退任記念特別)), E25-E35, 2013-01-31
- NAID 120005296655
- 福山型先天性筋ジストロフィーにおける発熱性疾患罹患後の筋力低下増悪に対する治療の検討
- 村上 てるみ,石垣 景子,佐藤 孝俊,梶野 幸子,齊藤 崇,大澤 眞木子,MURAKAMI Terumi,ISHIGAKI Keiko,SATO Takatoshi,KAJINO Sachiko,SAITO Takashi,OSAWA Makiko
- 東京女子医科大学雑誌 83(臨時増刊(大澤眞木子教授退任記念特別)), E36-E41, 2013-01-31
- NAID 120005296638
Related Links
- MDA leads the search for treatments and therapies for congenital muscular dystrophy (CMD). The Association also provides comprehensive supports and expert clinical care for those living with CMD. In this section, you'll find up-to-date ...
Related Pictures
★リンクテーブル★
[★]
- 英
- muscular dystrophy MD
- 同
- 筋異栄養症
- 関
- 筋ジストロフィー症、筋ジストロフィ、筋ジス、進行性筋ジストロフィー
[★]
- 英
- congenital muscular dystrophy CMD
先天性筋ジストロフィー
[★]
[★]
福山型先天性筋ジストロフィー
[★]
- (医)栄養失調、栄養失調症。(医)異栄養、異栄養症、ジフトロフィー
- 栄養障害。細胞や組織の物質代謝障害によって変性・萎縮などの起こること。
[★]
- 関
- congenital、congenitally
[★]
- 関
- muscle、muscularis、musculus、myo
[★]
[★]
筋ジストロフィー MD